Eur Respir J 1995; 8: 1286-1292
Copyright © ERS Journals Ltd 1995
Increased oxidation of extracellular glutathione by bronchoalveolar inflammatory cells in diffuse fibrosing alveolitis
J Behr,
B Degenkolb,
K Maier,
B Braun,
T Beinert,
F Krombach,
C Vogelmeier,
and
G Fruhmann
An unbalanced oxidative stress is thought to be an important element in the pathogenesis of diffuse fibrosing alveolitis (DFA). The purpose of our study was to investigate the role of reactive oxygen metabolites (ROMs) released from cultured bronchoalveolar inflammatory cells (BA-cells) on glutathione oxidation. We studied bronchoalveolar lavage samples from 10 healthy controls and from 20 patients with diffuse fibrosing alveolitis (all were nonsmokers). BA-cells obtained by bronchoalveolar lavage (BAL) were incubated with 50 microM of reduced glutathione (GSH). Oxidation of GSH to glutathione disulphide (GSSG) by BA-cell derived oxidants was detected as a decline of GSH in the supernatants. Total glutathione (GSHtot = GSH + 2 GSSG) and GSSG in the epithelial lining fluid (ELF), and methionine sulphoxide (Met(O)) content of BAL proteins were determined. In diffuse fibrosing alveolitis the oxidative activity of BA-cells was enhanced, GSHtot and GSH were decreased, whereas the GSSG:GSH ratio was increased. The oxidative activity of BA-cells correlated positively with the GSSG:GSH ratio, but not with the methionine sulphoxide content. The methionine sulphoxide content was elevated in diffuse fibrosing alveolitis and inversely correlated with GSHtot. The methionine sulphoxide content also correlated positively with the percentage of BAL neutrophils. We conclude that BA-cell-derived reactive oxygen species are capable of oxidizing extracellular GSH in vitro. The positive correlation between the BA-cell oxidative activity in vitro and GSSG:GSH ratio in ELF suggests that a similar oxidative effect on extracellular GSH may also occur in vivo.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:

|
 |

|
 |
 
Y. Kabuyama, K. Oshima, T. Kitamura, M. Homma, J. Yamaki, M. Munakata, and Y. Homma
Involvement of selenoprotein P in the regulation of redox balance and myofibroblast viability in idiopathic pulmonary fibrosis.
Genes Cells,
November 1, 2007;
12(11):
1235 - 1244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. L. Kinnula, C. L. Fattman, R. J. Tan, and T. D. Oury
Oxidative Stress in Pulmonary Fibrosis: A Possible Role for Redox Modulatory Therapy
Am. J. Respir. Crit. Care Med.,
August 15, 2005;
172(4):
417 - 422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Bishop, V. M. Hudson, S. C. Hilton, and C. Wilde
A Pilot Study of the Effect of Inhaled Buffered Reduced Glutathione on the Clinical Status of Patients With Cystic Fibrosis
Chest,
January 1, 2005;
127(1):
308 - 317.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Griese, J. Ramakers, A. Krasselt, V. Starosta, S. van Koningsbruggen, R. Fischer, F. Ratjen, B. Mullinger, R. M. Huber, K. Maier, et al.
Improvement of Alveolar Glutathione and Lung Function but Not Oxidative State in Cystic Fibrosis
Am. J. Respir. Crit. Care Med.,
April 1, 2004;
169(7):
822 - 828.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Neurohr, A-G. Lenz, I. Ding, H. Leuchte, T. Kolbe, and J. Behr
Glutamate-cysteine ligase modulatory subunit in BAL alveolar macrophages of healthy smokers
Eur. Respir. J.,
July 1, 2003;
22(1):
82 - 87.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Pardo, V. Ruiz, J. L. Arreola, R. Ramirez, J. Cisneros-Lira, M. Gaxiola, R. Barrios, S. V. Kala, M. W. Lieberman, and M. Selman
Bleomycin-induced Pulmonary Fibrosis Is Attenuated in {gamma}-Glutamyl Transpeptidase-Deficient Mice
Am. J. Respir. Crit. Care Med.,
March 15, 2003;
167(6):
925 - 932.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-D. WANG, M. YAMAYA, S. OKINAGA, Y.-X. JIA, M. KAMANAKA, H. TAKAHASHI, L.-Y. GUO, T. OHRUI, and H. SASAKI
Bilirubin Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats
Am. J. Respir. Crit. Care Med.,
February 1, 2002;
165(3):
406 - 411.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Behr, K Maier, B Degenkolb, F Krombach, and C Vogelmeier
Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression
Am. J. Respir. Crit. Care Med.,
December 1, 1997;
156(6):
1897 - 1901.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M Yaekashiwa, S Nakayama, K Ohnuma, T Sakai, T Abe, K Satoh, K Matsumoto, T Nakamura, T Takahashi, and T Nukiwa
Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphologic study
Am. J. Respir. Crit. Care Med.,
December 1, 1997;
156(6):
1937 - 1944.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1995 by the European Respiratory Society.
|